Growth Report for Third Quarter 2009 - Part I 3 comments
an article to
-
Font Size:
-
Print
- TweetThis
The third quarter earnings season is about over. It's time to take stock (no pun intended, well, maybe it was).
After each quarter's earnings season, I try to pull together what I call the Growth Report. Part 1 compiles the list of stocks that have shown a year-over-year increase in both revenue and earnings AND a sequential quarter-over-quarter increase in both revenue and earnings. Given the perception that the economic downturn is easing, it will be interesting to see how many companies have been able to to pull off this trick.
The following table presents a comparison of the last three quarters:
| Q1-2009 | Q2-2009 | Q3-2009 | |
|---|---|---|---|
| In S&P 500 | 27 | 41 | 39 |
| All stocks | 218 | 312 | 281 |
The number of stocks in the S&P 500 that qualified as growth leaders and made it onto the Q2 Growth Report grew by 50% over the first quarter. Comparisons, however, are becoming more difficult. In Q3, we are actually seeing a small decrease is the number of growth leaders as compared to Q2.
Repeat winners --
There are 33 stocks that managed to make the list in all three quarters this year. These stocks are not only growth leaders they are truly consistent growth leaders during difficult economic times. Here's the list :
| Symbol | Name |
|---|---|
| AIRM | Air Methods Corporation |
| AMED | Amedisys Inc |
| APT | ALPHA PRO TECH, LTD. |
| ASIA | AsiaInfo Holdings, Inc. |
| CACC | Credit Acceptance Corporation |
| CNU | CONTINUCARE CORPORATION |
| COCO | Corinthian Colleges, Inc. |
| CRM | SALESFORCE.COM, INC. |
| CRN | CORNELL COMPANIES, INC. |
| CTFO | China TransInfo Technology Corp. |
| CUB | CUBIC CORPORATION |
| EBIX | Ebix Inc |
| EBS | EMERGENT BIOSOLUTIONS, INC. |
| FMR | FIRST MERCURY FINANCIAL CORPORATION |
| GTS | TRIPLE-S MANAGEMENT CORP. |
| HTS | HATTERAS FINANCIAL CORP. |
| IDCC | InterDigital, Inc. |
| INMD | IntegraMed America, Inc. |
| LINC | Lincoln Educational Services Corporation |
| MED | MEDIFAST, INC. |
| NHC | NATIONAL HEALTHCARE CORP. |
| ORLY | O'Reilly Automotive, Inc. |
| ROST | Ross Stores, Inc. |
| SEP | SPECTRA ENERGY PARTNERS, LP |
| SF | STIFEL FINANCIAL CORP. |
| SQM | SOCIEDAD QUIMICA Y MINERA DE CHILE SA |
| SVT | SERVOTRONICS, INC. |
| TNDM | Neutral Tandem, Inc. |
| TRU | TORCH ENERGY ROYALTY TRUST |
| TSTC | Telestone Technologies Corp. |
| TYL | TYLER TECHNOLOGIES, INC. |
| VIT | VANCEINFO TECHNOLOGIES INC |
| YORW | The York Water Company |
Interestingly, this is exactly half as many stocks as we saw when combining Q1 and Q2.
Conclusion --
Even as many companies beat earnings estimates this quarter, there was still much concern over the fact that revenues were not growing as fast as many analysts had hoped. Again, cost cutting helped many companies achieved their profitable results. Our results seem to bear this out - there was no increase in the number of stocks that registered sequential and year-over-year increases in revenues and earnings. Indeed, the numbers decreased a litlle.
This makes the achievement of the stocks that did register strong results all the more remarkable.
You can click this link to download a spreadsheet that lists all the individual stocks that qualified for the Q3 Growth Report.
Stay tuned for Part 2 of the Q3 Growth Report where we discuss the those stocks that raised their dividends in the last quarter.
Related Articles
|























The conference call is well-worth listening to. I liked hearing that APT's overhead costs are less than 3Ms for producing masks, so they eat into 3Ms sales. And that they build their own production lines, so they can cheaply and easily expand as the necessity arises.
Also interesting is when our flu season ends, much of the world's begins, which is why specific masks for specific pandemics sell for 2 to 5 years rather than just a flu season. Also, APT smartly acquires hospitals needing, for example, H1N1 masks from anyone that has them into its new long-term customers, because APT's is better and competitively priced.
The best part of the conference call was when an analyst asked about whether APT would increase the price of the masks. The CEO said he wouldn't price gouge during a pandemic and that the only reason they would increase the price was if their production costs increased. He said, they're making more than enough on the masks and that, by putting out a good product during pandemics, they've gradually grown their sales to hospitals which continue to use them afterwards.
Smart, honest, solid management and a product that will be needed as long as pandemics exist as well as a growing customer base make APT a sound buy.